Product Comparison


  Tolmar Pharmaceuticals 62935022305 Fresenius USA 63323011751 APP Pharmaceuticals 63323011710 Pfizer 61703035038 Teva 00703367501
McKesson # 1019216 788329 479124 918013 825593
Description Eligard® Leuprolide Acetate 22.5 mg Injection 0.375 mL Fluorouracil 50 mg / mL Injection 50 mL Fluorouracil 50 mg / mL Injection 10 mL Methotrexate Sodium 25 mg / mL Injection 2 mL Methotrexate Sodium, Preservative Free 25 mg / mL Injection 10 mL
Manufacturer # 6293502230563323011751633230117106170303503800703367501
Brand Eligard®    
Manufacturer Tolmar PharmaceuticalsFresenius USAAPP PharmaceuticalsPfizerTeva
Invoice ELIGARD KIT, SYR 22.5MG 3MONTHRXFLUOROURACIL, VL 2.5GM/50ML 50MLFLUOROURACIL, SDV 50MG/ML 10ML(10/CT)METHOTREXATE, VL 25MG/ML 2ML (5/BX)METHOTREXATE, SDV 25MG/ML 10ML
    Log In to Order   Log In to Order   Log In to Order   Log In to Order   Log In to Order

Comparison

Alternate Manufacturer Number 3450921128152613272612004877
Container Type Single-Dose KitPharmacy Bulk VialSingle-Dose VialVialSingle-Dose Vial
Generic Drug Code 1815597457974553846618936
Generic Drug Name Leuprolide AcetateFluorouracilFluorouracilMethotrexate SodiumMethotrexate Sodium, Preservative Free
NDC Number 6293502230563323011751633230117106170303503800703367501
Storage Requirements Requires Refrigeration
Strength 22.5 mg50 mg / mL50 mg / mL25 mg / mL25 mg / mL
Type SubcutaneousIntravenousIntravenousIntramuscular, Intravenous, or Intra-arterial
UNSPSC Code 5111180751442004514420045120220351202203
Volume 0.375 mL50 mL10 mL2 mL10 mL
Application Antineoplastic AgentAntineoplastic AgentAntineoplastic AgentAntineoplastic AgentAntineoplastic Agent
Country of Origin UnknownUnknownUnknownUnknownUnknown
Dosage Form InjectionInjectionInjectionInjectionInjection
Product Dating McKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 days
Features and Benefits
  • Each Kit Contains: 1 sterile syringe (Syringe A) pre-filled with the Atrigel® delivery system, 1 sterile syringe (Syringe B) pre-filled with leuprolide acetate powder, 1 long plunger rod for use with Syringe B, desiccant packs, 1 sterile safety needle
  • 1 Injection every 3 months
  • Contains preservative
  • Not for intrathecal or high-dose therapy
  • 5 vials supplied in each carton
  • Methotrexate injection (preservative free) injectable products may be given by the intramuscular, intravenous, intra-arterial or intrathecal route